These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18042810)

  • 1. Safety of enoxaparin bridge therapy in patients with mechanical heart valves.
    Dixon D; Peek B; Reeve R
    Ann Pharmacother; 2008 Jan; 42(1):143-4. PubMed ID: 18042810
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
    Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
    Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
    Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
    J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low INR-levels in certain mechanical heart valves?].
    Wittwer T
    Dtsch Med Wochenschr; 2010 Feb; 135(8):366. PubMed ID: 20166003
    [No Abstract]   [Full Text] [Related]  

  • 5. How useful is determination of anti-factor Xa activity to guide bridging therapy with enoxaparin? A pilot study.
    Hammerstingl C; Omran H; Tripp C; Poetzsch B
    Thromb Haemost; 2009 Feb; 101(2):325-32. PubMed ID: 19190817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical management of thrombosis in inherited factor VII deficiency: a description of two cases.
    Arellano-Rodrigo E; Gironella M; Nicolau I; Vila M
    Thromb Haemost; 2009 Feb; 101(2):402-4. PubMed ID: 19190828
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized trial comparing 1 mg of oral vitamin K with no treatment in the management of warfarin-associated coagulopathy in patients with mechanical heart valves.
    Ageno W; Garcia D; Silingardi M; Galli M; Crowther M
    J Am Coll Cardiol; 2005 Aug; 46(4):732-3. PubMed ID: 16098445
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence of thromboembolic complications in patients with mechanical heart valves with a subtherapeutic international normalized ratio.
    Dentali F; Riva N; Malato A; Saccullo G; Siragusa S; Ageno W
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):91-3. PubMed ID: 19154909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the quality of anticoagulant therapy in patients with mechanical heart valves: what are we waiting for?
    Herijgers P; Verhamme P
    Eur Heart J; 2007 Oct; 28(20):2424-6. PubMed ID: 17890728
    [No Abstract]   [Full Text] [Related]  

  • 10. Prosthetic heart valves and pregnancy.
    McLintock C; North RA; White HD
    Circulation; 2003 Dec; 108(23):e159-60; author reply e159-60. PubMed ID: 14662695
    [No Abstract]   [Full Text] [Related]  

  • 11. Bleeding events in patients receiving enoxaparin for the management of non-ST-elevation acute coronary syndrome (NSTEACS) at Dunedin Public Hospital, New Zealand.
    Al-Sallami H; Ferguson R; Wilkins G; Gray A; Medlicott NJ
    N Z Med J; 2008 Nov; 121(1285):87-95. PubMed ID: 19079441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction.
    Zeymer U; Gitt A; Jünger C; Bauer T; Heer T; Koeth O; Wienbergen H; Zahn R; Senges J
    Thromb Haemost; 2008 Jan; 99(1):150-4. PubMed ID: 18217147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal haemorrhage associated with enoxaparin.
    Crooke B; Callaway LK
    Intern Med J; 2007 Mar; 37(3):207-8. PubMed ID: 17316348
    [No Abstract]   [Full Text] [Related]  

  • 14. Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome.
    Ng FH; Wong SY; Lam KF; Chang CM; Lau YK; Chu WM; Wong BC
    Am J Gastroenterol; 2008 Apr; 103(4):865-71. PubMed ID: 18177451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding in patients with mechanical heart valves on warfarin: impact of target INR and of comorbidity.
    Njaastad AM; Abildgaard U
    J Intern Med; 2006 Dec; 260(6):596. PubMed ID: 17116014
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatal retroperitoneal haemorrhage associated with enoxaparin and impaired renal function.
    Quiles J; Avanzas P; Bueno H
    Int J Cardiol; 2005 Feb; 98(3):523-4. PubMed ID: 15708194
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful angioembolization treatment in a patient with a mechanical heart valve with hemorrhagic corpus luteum.
    Levin G; Badrieh A; Attari R; Sabag L; Safrai M; Rottenstreich A
    Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():126-128. PubMed ID: 30279009
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International normalized ratio patient self-management for mechanical valves: is it safe enough?
    Koerfer R; Reiss N; Koertke H
    Curr Opin Cardiol; 2009 Mar; 24(2):130-5. PubMed ID: 19532098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.
    Tetri S; Hakala J; Juvela S; Saloheimo P; Pyhtinen J; Rusanen H; Savolainen ER; Hillbom M
    Thromb Res; 2008; 123(2):206-12. PubMed ID: 18420258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.